Manufacturing technology company Berkshire Grey (NASDAQ:BGRY), which closed a combination with Revolution Acceleration in July 2021, announced over the weekend that it is being acquired by SoftBank in a take-private transaction priced at $1.40 per share.
The price marks a 24% premium over Berkshire Grey’s closing price on March 24 and a 7.6% boost over the $1.30 figure initially floated in SoftBank’s indication of interest in February.
But, this price tag at $375 million is of course a steep drop from the company’s $2.2 billion de-SPAC valuation. For SoftBank, the transaction is a chance to repeat a successful bet as it led a $263 million capital raise into the company in 2020 ahead of its SPAC deal, which it took as an opportunity to exit at the higher valuation, according to Pitchbook.
Berkshire Grey’s combination with Revolution Acceleration was announced at a time when SPAC enthusiasm was at fever pitch in February 2021. But, as the market turned hard against tech companies due to the combination of inflation and interest rate concerns, Berkshire Grey stock appeared to take more hits than it could contend with in the public market and it has been trading below $3 since March 2022.
Things were rocky for Berkshire Grey out of the gate as it reported $50.9 million in revenue for a net loss of -$153.4 million in its first year on the public market. While this was only a -14% drop from the revenue projections laid out in its initial de-SPAC presentation, it gradually dropped its 2022 guidance from $119 million to a $65 million to $75 million range while burning an adjusted EBITDA loss of -$25 million to -$30 million per quarter.
It gained some financial flexibility by entering an equity purchase agreement worth up to $75 million over three years with Lincoln Park in October 2022, but its R&D-heavy balance sheet may be better suited for the private market in the current climate.
Berkshire Grey produces turnkey automated packing and sorting facilities for corporate clients and grew to 57 systems at 16 sites as of last November. The promise of its business model was to gain an appropriate level of scale and then to reap recurring revenue from sites, shifting to a robotics-as-a-service provider.
Although this rollout has been slower than hoped at the beginning of its de-SPAC process, this thesis could still be proven correct with time and SoftBank could attempt another SPAC bite of the apple down the road.
The take-private transaction has already been approved by Berkshire Grey’s Board and the parties expect to close it in the third quarter of 2023.


Pyrophyte Acquisition Corp. II (NYSE:PAII.U) announced the pricing of its $175 million IPO and its units are expected to begin trading on the NYSE under the symbol “PAII.U”, Thursday, July 17, 2025. The new SPAC plans to focus its search on companies within the energy sector that constitute critical links in the supply chain of the...
At the SPAC of Dawn Rare earth miner MP Materials (NYSE:MP) was one of the early winners of the 2020 SPAC boom, having picked up momentum following its 2020 deal with Fortress Value. But, the company’s news that it will become a major supplier of battery materials for Apple’s empire of electronic devices has sent...
Solarius Capital Acquisition Corp. (NASDAQ:SOCAU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “SOCAU”, Wednesday, July 16, 2025. The new SPAC plans to combine with a target in the asset management, wealth management or financial services industries. Solarius Capital’s management team...
Exciting new things are coming for SPACInsider subscribers, and some have already arrived! This summer, SPACInsider is unveiling the SPACInsider Alerts App on iOS with an Android launch soon to follow. The app allows subscribers to stay ahead of the SPAC market with real-time, customizable filing alerts with instant notifications landing the moment that a...
At the SPAC of Dawn Futures are largely green with the CPI reading coming up, and several SPACs and de-SPACs have cause to feel bullish regardless of what the reading states. Pharma and beauty company Longevity Health (NASDAQ:XAGE) announced it will acquire plasma collection firm True Health ahead of market open in news that has...